Pictet Asset Management (UK)’s BioTelemetry, Inc. BEAT Stock Holding History

Pictet Asset Management (UK)’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,100	Closed	-$223K	–	1875
2020 Q4	$223K	Buy	+3,100	New	+$162K	﹤0.01%	1555

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Pictet Asset Management (UK)'s BEAT Position: Q1 2021 in Review

Pictet Asset Management (UK) sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 3,100 shares — an estimated $223K sold.

Pictet Asset Management (UK) first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $223K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Pictet Asset Management (UK) reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Pictet Asset Management (UK) sold 3,100 BioTelemetry, Inc. shares in Q1 2021, an estimated $223K.
Pictet Asset Management (UK) first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Pictet Asset Management (UK)'s BioTelemetry, Inc. position peaked at $223K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2021, filed 17 May 2021.